Researchers are working tirelessly to study the new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the disease it causes, Coronavirus Disease 2019 (COVID-19). To aid in their efforts, StemExpress will utilize its six nationwide Collection Centers to offer blood-derived samples and respiratory-related biofluids from confirmed positive COVID-19 patients.